JP2019505216A5 - - Google Patents

Download PDF

Info

Publication number
JP2019505216A5
JP2019505216A5 JP2018540723A JP2018540723A JP2019505216A5 JP 2019505216 A5 JP2019505216 A5 JP 2019505216A5 JP 2018540723 A JP2018540723 A JP 2018540723A JP 2018540723 A JP2018540723 A JP 2018540723A JP 2019505216 A5 JP2019505216 A5 JP 2019505216A5
Authority
JP
Japan
Prior art keywords
rodent
angptl8
gene
human
endogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540723A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019505216A (ja
JP6843872B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/016487 external-priority patent/WO2017136712A1/en
Publication of JP2019505216A publication Critical patent/JP2019505216A/ja
Publication of JP2019505216A5 publication Critical patent/JP2019505216A5/ja
Application granted granted Critical
Publication of JP6843872B2 publication Critical patent/JP6843872B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540723A 2016-02-04 2017-02-03 操作されたangptl8遺伝子を有する非ヒト動物 Expired - Fee Related JP6843872B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662291446P 2016-02-04 2016-02-04
US62/291,446 2016-02-04
PCT/US2017/016487 WO2017136712A1 (en) 2016-02-04 2017-02-03 Non-human animals having an engineered angptl8 gene

Publications (3)

Publication Number Publication Date
JP2019505216A JP2019505216A (ja) 2019-02-28
JP2019505216A5 true JP2019505216A5 (enExample) 2020-03-05
JP6843872B2 JP6843872B2 (ja) 2021-03-17

Family

ID=58044217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018540723A Expired - Fee Related JP6843872B2 (ja) 2016-02-04 2017-02-03 操作されたangptl8遺伝子を有する非ヒト動物

Country Status (14)

Country Link
US (1) US10582702B2 (enExample)
EP (1) EP3411392B1 (enExample)
JP (1) JP6843872B2 (enExample)
KR (1) KR102487839B1 (enExample)
CN (1) CN108779159B (enExample)
AU (1) AU2017213627B2 (enExample)
CA (1) CA3012693C (enExample)
ES (1) ES2908669T3 (enExample)
IL (1) IL260620B (enExample)
MA (1) MA43962A (enExample)
MX (1) MX2018009513A (enExample)
RU (1) RU2742354C2 (enExample)
SG (1) SG11201806176PA (enExample)
WO (1) WO2017136712A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2962277T3 (es) 2017-09-29 2024-03-18 Regeneron Pharma Roedores que comprenden un locus Ttr humanizado y métodos de uso
HRP20240999T1 (hr) 2018-07-16 2024-10-25 Regeneron Pharmaceuticals, Inc. Glodavački modeli bolesti ditra i njihova upotreba
WO2020206139A1 (en) 2019-04-04 2020-10-08 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized coagulation factor 12 locus
EP3801011A1 (en) 2019-06-04 2021-04-14 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
AU2020289581B2 (en) 2019-06-07 2024-11-21 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized albumin locus
CN114671943B (zh) * 2022-04-29 2023-05-05 四川大学 一种鱼类摄食调控蛋白的制备和应用
CN119367545B (zh) * 2025-01-02 2025-04-08 山东第一医科大学(山东省医学科学院) 靶向干预ANGPTL8 mRNA在制备治疗高同型半胱氨酸血症药物中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
EP1451578B1 (en) * 2001-11-16 2013-08-21 Genentech, Inc. Use of angptl3 antagonists for the treatment of liver diseases
US20050283054A1 (en) 2004-06-18 2005-12-22 Banner Health Evaluation of a treatment to decrease the risk of a progressive brain disorder or to slow brain aging
AU2005295269B2 (en) 2004-10-19 2010-05-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
JP2008532516A (ja) * 2005-03-11 2008-08-21 ジェネンテック・インコーポレーテッド 遺伝子破壊、組成物、およびそれに関連する方法
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
WO2011020014A1 (en) 2009-08-14 2011-02-17 Regeneron Pharmaceuticals, Inc. Promoter-regulated differentiation-dependent self-deleting cassette
CA3040377C (en) 2009-10-06 2025-12-30 Yale University Genetically modified mice and engraftment comprising the knock-in of a human thrombopoietin (tpo) gene
ES3040596T3 (en) 2011-02-15 2025-11-03 Regeneron Pharma Humanized m-csf mice and uses thereof
RS56330B1 (sr) * 2011-10-28 2017-12-29 Regeneron Pharma Genetski modifikovani miševi sa ekspresijom himernih molekula klase ii glavnog kompleksa histokompatibilnosti (mhc)
MY186903A (en) 2011-10-28 2021-08-26 Regeneron Pharma Humanized il-6 and il-6 receptor
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
KR102287541B1 (ko) 2012-09-07 2021-08-10 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
AU2014218931C1 (en) 2013-02-20 2020-05-14 Regeneron Pharmaceuticals, Inc. Genetic modification of rats
DK3175706T3 (en) 2013-09-23 2019-03-04 Regeneron Pharma Non-human animals with a humanized signal regulatory protein gene
SMT201900177T1 (it) 2013-10-15 2019-05-10 Regeneron Pharma Animali con il-15 umanizzata
CN105792646B (zh) 2013-11-19 2018-03-02 瑞泽恩制药公司 具有人源化的b细胞活化因子基因的非人动物
SG10201811701YA (en) 2013-11-19 2019-01-30 Regeneron Pharma Non-human animals having a humanized a proliferation-inducing ligand gene
NO2785538T3 (enExample) 2014-05-07 2018-08-04
KR20250096864A (ko) 2014-05-19 2025-06-27 리제너론 파마슈티칼스 인코포레이티드 인간 epo를 발현하는 유전자 변형된 비-인간 동물
HUE048677T2 (hu) * 2014-06-19 2020-07-28 Regeneron Pharma Humanizált programozott sejthalál 1 génnel rendelkezõ nem-humán állatok
US10071139B2 (en) * 2014-10-03 2018-09-11 Ngm Biopharmaceuticals, Inc. Methods for treatment of conditions associated with elevated triglycerides with an ANGPTL8 polypeptide fragment
KR102617691B1 (ko) 2014-12-05 2023-12-27 리제너론 파마슈티칼스 인코포레이티드 인간화 분화 클러스터 47 유전자를 가진 비인간 동물
NZ731954A (en) 2014-12-09 2024-11-29 Regeneron Pharma Non-human animals having a humanized cluster of differentiation 274 gene
CN105671189A (zh) * 2016-04-03 2016-06-15 信阳师范学院 一种基于黄牛Angptl8基因单核苷酸多态性的分子育种方法

Similar Documents

Publication Publication Date Title
JP2019505216A5 (enExample)
JP7755699B2 (ja) ヒト化IL-4およびIL-4Rα動物
JP2017521060A5 (enExample)
US10945418B2 (en) Genetically modified non-human animal with human or chimeric PD-L1
JP2018500896A5 (enExample)
ES2779070T3 (es) Animales con C5 y C3 humanizadas
JP2018533963A5 (enExample)
US11279948B2 (en) Genetically modified non-human animal with human or chimeric OX40
US11505806B2 (en) Genetically modified non-human animal with human or chimeric OX40
WO2018041118A1 (en) Genetically modified non-human animal with human or chimeric pd-l1
JP2011501652A5 (enExample)
CN108588126A (zh) Cd47基因人源化改造动物模型的制备方法及应用
JP2017514501A5 (enExample)
FI3823443T3 (fi) Ditra-taudin jyrsijämallit ja niiden käyttö
RU2018130003A (ru) Животные, отличные от человека, имеющие сконструированный ген angptl8
JP2021169461A (ja) 寿命に関する動物モデル並びに寿命を延ばす及び腫瘍化を阻害する関連方法
JP7504030B2 (ja) 進行性骨化性線維異形成症のげっ歯類モデル
JP2018512842A5 (enExample)
CN112501202B (zh) Cxcr4基因人源化的非人动物及其构建方法和应用
JP2024500153A (ja) ヒト化tslp遺伝子、ヒト化tslp受容体遺伝子、及び/又はヒト化il7ra遺伝子を有する非ヒト動物
WO2022253280A1 (en) Genetically modified non-human animal with human or chimeric bcma
JPWO2022140221A5 (enExample)
RU2788523C2 (ru) ЖИВОТНЫЕ С ГУМАНИЗИРОВАННЫМИ IL-4 И IL-4Rα
KR20150122373A (ko) 뇌하수체 종양 동물모델